| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $268K | — | -54.9% |
| SG&A Expense | $36.6M | — | +1774.4% |
| Operating Income | -$36.9M | — | -1347.7% |
| Pre-tax Income | -$51.6M | — | -1928.7% |
| Income Tax | -$4.2M | — | — |
| Net Income | -$47.3M | — | -1762.7% |
| EPS (Basic) | -$0.23 | — | +76.8% |
| EPS (Diluted) | -$0.23 | — | +76.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $43.1M | +147.8% | +2493.5% |
| Total Assets | $584.7M | +12.6% | — |
| Current Liabilities | $1.1M | -65.3% | -53.9% |
| Total Liabilities | $114.9M | -5.3% | +4538.8% |
| Stockholders' Equity | $469.8M | +18.1% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.6M | — | -183.9% |
| Investing Cash Flow | -$54.8M | — | — |
| Financing Cash Flow | $87.0M | — | — |